|
The role of tunneling nanotubes as a novel mode of tumor cell-macrophage communication
|
5F99CA212451-02
|
$44,044
|
|
HANNA, SAMER
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Novel approaches to study immune responses to post translational modifications for cancer detection
|
5U01CA214201-02
|
$462,286
|
|
LABAER, JOSHUA
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Couple Communication in Cancer: A Multi-Method Examination
|
5R01CA201179-02
|
$650,269
|
|
LANGER, SHELBY
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
High Resolution High Throughput Proteomics Platform for Cancer Research
|
1R33CA217699-01
|
$410,858
|
|
IBRAHIM, YEHIA
|
BATTELLE PACIFIC NORTHWEST LABORATORIES
|
|
PNNL Proteome Characterization Center
|
5U24CA210955-02
|
$1,091,415
|
|
LIU, TAO
|
BATTELLE PACIFIC NORTHWEST LABORATORIES
|
|
SPORE in Lymphoma
|
2P50CA126752-11
|
$3,097,657
|
|
HESLOP, HELEN
|
BAYLOR COLLEGE OF MEDICINE
|
|
iPGDAC, An Integrative Proteogenomic Data Analysis Center for CPTAC
|
5U24CA210954-02
|
$973,045
|
|
ZHANG, BING
|
BAYLOR COLLEGE OF MEDICINE
|
|
Discovery and Characterization of Mutations in Breast and Ovarian Cancers
|
5R50CA211280-02
|
$215,047
|
|
ADAMSON, AARON
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Functional Analysis of Structure Specific Nucleases in Genome Stability and Cancers
|
5R50CA211397-02
|
$282,253
|
|
ZHENG, LI
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
A National Curriculum in Cancer Genomics for Residents and Medical Students
|
2R25CA168544-06
|
$255,425
|
|
HASPEL, RICHARD
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Mechanisms of extracellular matrix mediated drug resistance
|
5R00CA180221-04
|
$248,999
|
|
MURANEN, TARU
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Molecular and Imaging Biomarkers for Early Lung Cancer Detection in the Setting of Indeterminate Pulmonary Nodules
|
5R01CA210360-02
|
$627,525
|
|
SPIRA, AVRUM
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
The Boston University-UCLA Lung Cancer Biomarker Development Lab
|
5U01CA214182-02
|
$860,456
|
|
SPIRA, AVRUM
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Studying the Role of Aneuploidy in Cancer Immune Evasion
|
5K99CA212621-02
|
$137,124
|
|
DAVOLI, TERESA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
SPORE in Myeloid Malignancies
|
1P50CA206963-01A1
|
$2,185,000
|
|
EBERT, BENJAMIN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Global Infrastructure for Collaborative High-throughput
|
5U24CA210999-02
|
$941,937
|
|
GETZ, GAD
|
BROAD INSTITUTE, INC.
|
|
High Content Screening of Multicellular Invasion with 3D Traction Force Microscopy
|
1R21CA212932-01A1
|
$185,674
|
|
WONG, IAN
|
BROWN UNIVERSITY
|
|
Steady states and cellular transitions associated with carcinogenesis and tumor progression
|
1U01CA217655-01
|
$644,276
|
|
HEATH, JAMES
|
CALIFORNIA INSTITUTE OF TECHNOLOGY
|
|
Computational Genomic Epidemiology of Cancer (CoGEC) Training Program
|
2T32CA094186-16
|
$302,360
|
|
LI, LI
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case GI SPORE
|
2P50CA150964-06A1
|
$2,375,000
|
|
MARKOWITZ, SANFORD
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Identifying epigenetic drivers and their targets in aggressive breast and ovarian cancers
|
5F99CA212460-02
|
$33,366
|
|
SAHNI (BRANCATO), JENNIFER
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Corrole nanobiologics for targeting resistant and metastatic tumors
|
5R01CA140995-07
|
$415,625
|
|
MEDINA-KAUWE, LALI
|
CEDARS-SINAI MEDICAL CENTER
|
|
Discovering and Exploiting Mechanisms of Neuroblastoma Therapy Resistance
|
1P01CA217959-01
|
$2,296,936
|
|
SEEGER, ROBERT
|
CHILDREN'S HOSPITAL OF LOS ANGELES
|
|
CryoPen: An Innovative Treatment for Cervical Precancer in Low-Resource Setting
|
5UH3CA189883-05
|
$936,421
|
|
CREMER, MIRIAM
|
CLEVELAND CLINIC LERNER COM-CWRU
|
|
Automated Problem and Allergy Lists Enrichment Based on High Accuracy Information Extraction from the Electronic Health Record
|
5R42CA180190-03
|
$767,485
|
|
MEYSTRE, STEPHANE
|
CLINACUITY,INC.
|
|
Improving specificity of HPV Screen-and-Treat in South Africa
|
5UH3CA189908-04
|
$962,232
|
|
KUHN, LOUISE
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Evolutionary Heterogeneity of High Grade Glioma
|
5F99CA212478-02
|
$41,110
|
|
LADEWIG, ERIK
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Genomics and Mechanisms of Esophageal Carcinogenesis
|
5R01CA208711-02
|
$366,000
|
|
SEPULVEDA, ANTONIA
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
(PQD2) Molecular Basis for the Chemosensitivity of Testicular Germ Cell Cancers
|
5R21CA185256-02
|
$202,275
|
$202,275
|
WEISS, ROBERT
|
CORNELL UNIVERSITY
|
|
A high efficiency imager for real-time lung cancer monitoring during radiotherapy
|
3R01CA188446-04S1
|
$256,320
|
|
BERBECO, ROSS
|
DANA-FARBER CANCER INST
|
|
Material Hardship as a Targetable Measure of Poverty in Pediatric Cancer
|
5K07CA211847-02
|
$133,475
|
|
BONA, KIRA
|
DANA-FARBER CANCER INST
|
|
Human Cancer Suppressor Functions of Protein Phosphatase 2A
|
1P01CA203655-01A1
|
$1,613,905
|
|
DECAPRIO, JAMES
|
DANA-FARBER CANCER INST
|
|
Maximum efficiency sequencing using nuclease-based mutation enrichment and digital barcodes
|
1R33CA217652-01
|
$456,746
|
|
MAKRIGIORGOS, G.
|
DANA-FARBER CANCER INST
|
|
Immunogenomic analytical approaches for research and clinical applications
|
5R50CA211482-02
|
$265,958
|
|
SHUKLA, SACHET
|
DANA-FARBER CANCER INST
|
|
2/2 The University of Massachusetts, Boston - Dana-Farber/Harvard Cancer Center U54 Comprehensive Partnership for Cancer Disparities Research
|
5U54CA156732-07
|
$1,834,682
|
$256,855
|
VISWANATH, KASISOMAYAJULA
|
DANA-FARBER CANCER INST
|
|
Low Cost Automated Ultrasound for Breast Cancer Detection and Diagnosis
|
5UH3CA189966-04
|
$1,000,000
|
|
LOVE, SUSAN
|
DR. SUSAN LOVE RESEARCH FOUNDATION
|
|
Breast Cancer Detection Consortium
|
5U01CA214183-02
|
$454,587
|
|
MARKS, JEFFREY
|
DUKE UNIVERSITY
|
|
A hands-on, integrative next-generation sequencing course: design, experiment, a
|
R25EB023928-02
|
$161,038
|
|
Owzar, Kouros
|
DUKE UNIVERSITY
|
|
2/2 NCCU-DUKE Cancer Disparities Translational Research Partnership
|
5P20CA202925-02
|
$255,626
|
|
PATIERNO, STEVEN
|
DUKE UNIVERSITY
|
|
Household Air Pollution and Health: A Multi-Country LPG Intervention Trial
|
UM1HL134590-02
|
$1,000,000
|
|
Clasen, Thomas
|
EMORY UNIVERSITY
|
|
Planning a Regional Center of Research Excellence in Non-communicable Diseases in India
|
5P20CA210298-02
|
$242,714
|
|
GOODMAN, MICHAEL
|
EMORY UNIVERSITY
|
|
A unique approach combining avatar mice and targeted mass spectrometry to identify blood biomarkers for early detection of breast cancer
|
5U01CA214172-02
|
$565,399
|
|
PAULOVICH, AMANDA
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Using functional genomics to inform gene environment interactions for colorectal cancer
|
5R01CA201407-02
|
$2,103,158
|
|
PETERS, ULRIKE
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
A proteomics research specialist in developing targeted mass spectrometry methods for quantifying proteins important in cancer
|
5R50CA211499-02
|
$257,484
|
|
WHITEAKER, JEFF
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Impact of Cytoskeletal Regulators on Cancer Cell Stromal Invasion
|
5F99CA212132-02
|
$31,344
|
|
BERENS, ERIC
|
GEORGETOWN UNIVERSITY
|
|
Impact of aging on progression and prevention of mammary preneoplasia and cancer
|
5UH2CA213388-02
|
$75,386
|
|
FURTH, PRISCILLA
|
GEORGETOWN UNIVERSITY
|
|
Programa de ARBOLES Familiares: Assessing Risk of Breast Cancer through Outreach to Latinas with Education and Support
|
1R25CA217723-01
|
$320,201
|
|
GRAVES, KRISTI
|
GEORGETOWN UNIVERSITY
|
|
DNA Methyltransferase Target Sites in Cancer
|
5F31CA171727-03
|
$38,670
|
$3,867
|
TIEDEMANN, ROCHELLE
|
GEORGIA REGENTS UNIVERSITY
|
|
Next-Generation Antibody Discovery and Development Technology
|
5R44CA187852-03
|
$480,577
|
|
JOHNSON, DAVID
|
GIGAGEN, INC.
|
|
Targeting the adenosine A2A receptor immune checkpoint in lung cancer patients
|
5R01CA201124-02
|
$259,646
|
|
ANTONIA, SCOTT
|
H. LEE MOFFITT CANCER CTR & RES INST
|
Total relevant funding to Testes for this search: $5,201,365
|